A team of researchers from IBEC and the Faculty of Medicine and Health Sciences at the University of Barcelona have designed a device based on microfluidic physics to predict the efficacy of cancer treatments in a fast and automated way, they have named it microfluidic dynamic BH3 profiling (μDBP). This system brings cancer cells, from the biopsy, into contact with different therapeutic options to identify ex vivo those that could be most effective in eliminating the tumor.
You can read the news at:
